Cancer
Scientists have discovered that the Lewis-Y carbohydrate antigen is expressed on a range of tumors, including squamous cell lung carcinoma, lung adenocarcinoma, ovarian carcinoma, and colorectal adenocarcinoma. Specifically, 42% of squamous cell lung carcinoma, 80% of lung adenocarcinoma, 25% of ovarian carcinoma, and 25% of colorectal adenocarcinoma expressed Lewis-Y. Furthermore,
Cancer research
Researchers at Harvard University have discovered that neamine, a nontoxic degradation product of neomycin, can inhibit the growth of prostate cancer cells by blocking the nuclear translocation of angiogenin (ANG). This study, published in Clinical Cancer Research, found that neamine not only inhibited xenograft growth of PC-3 human prostate cancer
Cancer research
Researchers at Washington University have discovered that some quinones, which are metabolized from phenolic substances, can have both beneficial and deleterious health effects. Specifically, they found that catechol genistein quinone (CGenQ) has a short half-life and disappears quickly by reacting with water, whereas catechol estrogen quinones (CEO) are more long-lived
Cancer
Researchers at Baylor College of Medicine have conducted a study to evaluate the chemopreventive effects of three agents, rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib, on mammary tumor development in p53-null mammary epithelium. The study found that rexinoid bexarotene was the most efficacious inhibitor, reducing mammary tumor development by
Cancer
Scientists have developed a novel drug delivery system that targets specific cancer cells using a monoclonal antibody. The system, which uses doxorubicin-loaded, long-circulating liposomes, has shown significant improvement in tumor accumulation and therapeutic effect compared to traditional treatments. Researchers at Northeastern University, led by T. Elbayoumil, conducted a study in
Cancer
Researchers at Ningbo University in the People's Republic of China have discovered a significant synergistic effect when combining docosahexaenoic acid (DHA) and 5-fluorouracil (5-FU) in suppressing the growth of gastric carcinoma cells. This study suggests that DHA enhances the anticancer effect of 5-FU by increasing the early phase
Cancer research
Recent research from Cork, Ireland, presents a breakthrough in cancer treatment by combining gene therapy and radiotherapy to tackle breast cancer. This novel approach, known as gene-radiotherapy, has shown significant potential in controlling both local and systemic breast cancer. The study aimed to evaluate the antitumor effects of interferon (IFN)
Cancer research
Genistein, a natural isoflavone found in soy and other plant-based foods, has been shown to have a significant impact on the growth of renal cancer cells. A study published in Carcinogenesis found that genistein can demethylate the promoter of the BTG3 tumor suppressor gene, leading to histone modification and cell
Cancer
Researchers at the University of Cologne in Germany have published a study in the Annals of Surgical Oncology, finding that DAPK (Death-Associated Protein Kinase) methylation in pretreatment biopsies of patients with locally advanced cancer of the esophagus is not a reliable marker for predicting histomorphological regression or prognosis following neoadjuvant
Cancer research
Researchers at the National Cancer Institute in the United States conducted a retrospective analysis of dermatologic toxicity in patients receiving combined antiangiogenic therapy involving sorafenib and bevacizumab. The study aimed to determine the probability of developing maximum grade dermatologic toxicity as a function of the cumulative dose of sorafenib. The
Cancer research
A team of scientists from the University of Zurich has made a significant discovery in the field of anticancer therapy. They investigated the combined treatment modality of ionizing radiation (IR) and the microtubule-stabilizing compound patupilone (epothilone 13, EP0906) in non-small cell lung cancer cells. The research team found that the
Cancer
In a groundbreaking study published in the journal Cancer Immunology, Immunotherapy, researchers from the University of Kentucky have made a startling discovery about the effects of a homodimerizing antibody on human non-small cell lung cancer cells. Contrary to conventional wisdom, the study found that increasing the concentration of the antibody
